{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:53:14Z","timestamp":1781671994966,"version":"3.54.5"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T00:00:00Z","timestamp":1779494400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gynecologic Oncology Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.gore.2026.102120","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:10:42Z","timestamp":1779952242000},"page":"102120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Isolated ovarian metastasis in otherwise cervix-confined adenocarcinoma of the cervix: A rare clinical conundrum"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5077-4299","authenticated-orcid":false,"given":"Lauren M.","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Speck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Urban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9229-5181","authenticated-orcid":false,"given":"Margaret I.","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gore.2026.102120_b0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.gore.2026.102120_b0010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/ijgc-2020-001257","article-title":"Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: a review of gaps and questions that remain","volume":"30","author":"Salvo","year":"2020","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2026.102120_b0015","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.gore.2026.102120_b0020","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ygyno.2005.10.004","article-title":"Ovarian metastasis in carcinoma of the uterine cervix","volume":"101","author":"Shimada","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102120_b0025","doi-asserted-by":"crossref","DOI":"10.1186\/s13048-017-0339-y","article-title":"Ovarian preservation in adenocarcinoma of the uterine cervix","volume":"10","author":"Zhou","year":"2017","journal-title":"J. Ovarian Res."},{"key":"10.1016\/j.gore.2026.102120_b0030","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/ijc.31084","article-title":"Identifying a candidate population for ovarian conservation in young women with clinical stage IB\u2013IIB cervical cancer","volume":"142","author":"Matsuo","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.gore.2026.102120_b0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2018.10.026","article-title":"Validation of the 2018 FIGO cervical cancer staging system","volume":"152","author":"Matsuo","year":"2019","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102120_b0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/AOG.0000000000003311","article-title":"Prognostic performance of the 2018 International Federation of Gynecology and Obstetrics cervical cancer staging guidelines","volume":"134","author":"Wright","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.gore.2026.102120_b0045","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1447-0756.2008.01005.x","article-title":"Unilateral ovarian metastasis in a case of squamous cervical carcinoma IA1","volume":"35","author":"Kang","year":"2009","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.gore.2026.102120_b0050","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1006\/gyno.1999.5387","article-title":"A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study","volume":"73","author":"Sedlis","year":"1999","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.gore.2026.102120_b0055","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00006254-200008000-00017","article-title":"Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix","volume":"55","author":"Peters","year":"2000","journal-title":"Obstet. Gynecol. Surv."},{"key":"10.1016\/j.gore.2026.102120_b0060","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1200\/JCO.23.00914","article-title":"First-line pembrolizumab + chemotherapy versus placebo + chemotherapy for persistent, recurrent, or metastatic cervical cancer: final overall survival results of KEYNOTE-826","volume":"41","author":"Monk","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gore.2026.102120_b0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(23)02405-4","article-title":"Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial","volume":"403","author":"Oaknin","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.gore.2026.102120_b0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/annonc\/mdu116","article-title":"Optimal treatment of early-stage ovarian cancer","volume":"25","author":"Collinson","year":"2014","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.gore.2026.102120_b0075","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1136\/ijgc-00009577-200705000-00011","article-title":"Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)","volume":"17","author":"Landoni","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.gore.2026.102120_b0080","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0020-7292(97)02848-8","article-title":"Ovarian metastasis from cervical carcinoma","volume":"57","author":"Wu","year":"1997","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"10.1016\/j.gore.2026.102120_b0085","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0002-9378(92)91828-X","article-title":"Ovarian metastases in stage IB carcinoma of the cervix: a Gynecologic Oncology Group study","volume":"166","author":"Sutton","year":"1992","journal-title":"Am. J. Obstet. Gynecol."}],"container-title":["Gynecologic Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352578926001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T04:06:58Z","timestamp":1781669218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352578926001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":17,"alternative-id":["S2352578926001001"],"URL":"https:\/\/doi.org\/10.1016\/j.gore.2026.102120","relation":{},"ISSN":["2352-5789"],"issn-type":[{"value":"2352-5789","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolated ovarian metastasis in otherwise cervix-confined adenocarcinoma of the cervix: A rare clinical conundrum","name":"articletitle","label":"Article Title"},{"value":"Gynecologic Oncology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gore.2026.102120","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102120"}}